The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Possible mechanisms underlying the development of cachexia in COPD
Open accessAbstract
About 25% of patients with chronic obstructive pulmonary disease (COPD) will develop cachexia (fat-free body mass index <17 kg·m−2(males) or <14 kg·m−2(females)). This is associated with ∼50% reduction in median survival. The pathogenetic mechanism has been variously suggested to result from the following: 1) energy imbalance; 2) disuse atrophy; 3) tissue hypoxia from arterial hypoxaemia; 4) systemic inflammation; and 5) anabolic hormonal insufficiency. Genetic polymorphisms implicate inflammatory cytokines, especially interleukin (IL)-1β, but IL-6 and tumour necrosis factor (TNF)-α do not show polymorphisms in these patients. Early reports of elevated TNF-α levels suggested a role for inflammation, but recent studies have not shown elevated levels of either IL-6 or TNF-α. Therapeutic trials of nutritional support, hormonal supplementation, anti-TNF-α immunotherapy, ghrelin and antioxidants have been conducted, but only a few have shown any benefits in muscle structure and function. Considerably more mechanistic knowledge is needed before therapeutic recommendations can be made. At this time, it is not possible to attribute cachexia in COPD unequivocally to inflammation or any other cause, and much more research is needed. To date, studies have been predominantly cross-sectional, with measurements made only after cachexia has developed. Future research should target prospective observation, studying patients as cachexia progresses, since once cachexia is established, inflammatory cytokine levels may not be abnormal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.
Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., & Feingold, K. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118653 · Cited by 862
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791
Cachexia: pathophysiology and clinical relevance1,2
Morley, J. E., Thomas, D. R., & Wilson, M.-M. G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.735 · Cited by 786
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Body composition and mortality in chronic obstructive pulmonary disease
Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.53 · Cited by 658
Alveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527
Thomas, D. R. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.03.008 · Cited by 521 · cited 1×
“Since ageing is associated with loss of lean body mass [ 50 ], it is possible that those subjects with COPD who develop cachexia are those who, in the absence of their disease, would have shown accelerated ageing and loss of lean body mass.”
BackgroundLi, Y.-P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 499
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Skeletal muscle loss: cachexia, sarcopenia, and inactivity
Evans, W. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608a · Cited by 723
Cavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
Nutritional supplementation for stable chronic obstructive pulmonary disease
Ferreira, I. M., Brooks, D., White, J., & Goldstein, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000998.pub3 · Cited by 326
Cachexia: A systemic consequence of progressive, unresolved disease
Ferrer, M., Anthony, T. G., Ayres, J. S., Biffi, G., Brown, J. C., Caan, B. J., Cespedes Feliciano, E. M., Coll, A. P., Dunne, R. F., Goncalves, M. D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.028 · Cited by 260
Metadata
- Authors
- Wagner, P. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2008-02-29
- Volume
- 31
- Issue
- 3
- Pages
- 492-501
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2159445530
- Cited by
- 280
- References
- 61
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Possible mechanisms underlying the development of cachexia in COPD. https://app.cochat.ai/papers/10.1183/09031936.00074807
- The paper
- Wagner, P. D. (2008). Possible mechanisms underlying the development of cachexia in COPD. European Respiratory Journal. https://doi.org/10.1183/09031936.00074807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.